Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Coast To Coast Tribune.
Press releases published on April 10, 2025
Oculis Completes Enrollment in both DIAMOND Phase 3 Trials of OCS-01 in Diabetic Macular Edema
GlobeNewswire
·
April 10, 2025
DIAMOND is the first and only pivotal trial program ever conducted with a topical treatment for diabetic macular edema (DME) Over 800 patients randomized in DIAMOND-1 or DIAMOND-2 Phase 3 trials at an industry-leading record speed across 119 sites …
Advanced PMIC for High-Performance AI, Industrial Computing and Data Center Applications
GlobeNewswire
·
April 10, 2025
CHANDLER, Ariz., April 10, 2025 (GLOBE NEWSWIRE) -- The rapid integration of AI into industrial, computing and data center applications is fueling a growing demand for more efficient and advanced power management solutions. Microchip Technology (Nasdaq: …
Northern Technologies International Corporation Reports Financial Results for Second Quarter Fiscal 2025
GlobeNewswire
·
April 10, 2025
MINNEAPOLIS, April 10, 2025 (GLOBE NEWSWIRE) -- Northern Technologies International Corporation (NASDAQ: NTIC), a leading developer of corrosion inhibiting products and services, as well as bio-based and biodegradable polymer resin compounds, today …
Vertex baut sein Chief Strategy Office aus, um e-Invoicing und globale Compliance-Initiativen voranzutreiben
GlobeNewswire
·
April 10, 2025
KING OF PRUSSIA, Pa., April 10, 2025 (GLOBE NEWSWIRE) -- Vertex Inc. (NASDAQ:VERX), ein globaler Anbieter von Technologielösungen für indirekte Steuern, gab heute die Erweiterung seines Chief Strategy Office (CSO) bekannt: Christopher Hall und Kathya …
Vertex Expands Chief Strategy Office to Advance E-Invoicing and Global Compliance Initiatives
GlobeNewswire
·
April 10, 2025
KING OF PRUSSIA, Pa., April 10, 2025 (GLOBE NEWSWIRE) -- Vertex Inc. (NASDAQ:VERX) (“Vertex” or the “Company”), a global provider of indirect tax technology solutions, today announced the expansion of its Chief Strategy Office (CSO) with the addition of …
Esperion to Host R&D Day to Highlight Cardiometabolic Pipeline Innovation and Next-Generation Therapeutics on April 24, 2025
GlobeNewswire
·
April 10, 2025
ANN ARBOR, Mich., April 10, 2025 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that it will host an in-person R…
Avalyn to Participate in Upcoming Investor Conference in April
GlobeNewswire
·
April 10, 2025
CAMBRIDGE, Mass., April 10, 2025 (GLOBE NEWSWIRE) -- Avalyn Pharma Inc., a clinical-stage biopharmaceutical company focused on development of inhaled therapies for the treatment of life-threatening pulmonary diseases, today announced that management will …
Global Clean Technology Innovators Honored in 2025 CleanTech Breakthrough Awards Program
GlobeNewswire
·
April 10, 2025
LOS ANGELES, April 10, 2025 (GLOBE NEWSWIRE) -- CleanTech Breakthrough, a leading independent market intelligence organization that evaluates and recognizes standout climate and clean technology companies, products and services around the globe, today …
Sibros and Electra Vehicles Join Forces to Enable AI-Powered Battery Intelligence for the Software-Defined Vehicle Era
GlobeNewswire
·
April 10, 2025
SAN JOSE, Calif. and BOSTON, April 10, 2025 (GLOBE NEWSWIRE) -- Sibros, a pioneer in connected vehicle software management systems, today announced a strategic partnership with Electra Vehicles, the leading AI, Cleantech, and B2B software company focused …
Imbria Pharmaceuticals Raises $57.5M Series B Financing Round and Appoints Alvin Shih, MD as CEO
GlobeNewswire
·
April 10, 2025
– Led by new investor Deep Track Capital, with participation from AN Ventures, Catalio Capital Management, Cytokinetics, Inc. and existing investors RA Capital Management and SV Health Investors – – Proceeds to support advancement of ninerafaxstat for the …
Calidi Biotherapeutics Announces Appointment of Guy Travis Clifton, MD as Chief Medical Officer, Consultant and Advisor
GlobeNewswire
·
April 10, 2025
SAN DIEGO, April 10, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company developing a new generation of targeted antitumor virotherapies, today announced the appointment of Guy …
FintechVendors.com Launches Free, Comprehensive Directory of 4,400+ Fintech Providers
GlobeNewswire
·
April 10, 2025
ORLANDO, Fla., April 10, 2025 (GLOBE NEWSWIRE) -- FintechVendors.com (FVC), a groundbreaking, free-to-use directory of over 4,400 fintech vendors, has officially launched to the public. FVC is designed to streamline the initial vendor discovery process, …
NV5 to Host First Quarter 2025 Conference Call on Thursday, May 1st at 4:30pm ET
GlobeNewswire
·
April 10, 2025
HOLLYWOOD, Fla., April 10, 2025 (GLOBE NEWSWIRE) -- NV5 Global, Inc. (the “Company” or “NV5”) (Nasdaq: NVEE), a provider of tech-enabled engineering, certification, and consulting solutions, will announce its financial results for the first quarter ended …
Theriva Biologics Announces Presentation of Data from the Phase 1b/2a Clinical Trial of SYN-004 (ribaxamase) in Allogeneic Hematopoietic Cell Transplant Recipients
GlobeNewswire
·
April 10, 2025
ROCKVILLE, Md., April 10, 2025 (GLOBE NEWSWIRE) -- Theriva Biologics (NYSE American: TOVX), (“Theriva” or the “Company”), a diversified clinical-stage company developing therapeutics designed to treat cancer and related diseases in areas of high unmet need …
Top Acquirers of Card Payments at US Merchants
GlobeNewswire
·
April 10, 2025
SANTA BARBARA, Calif., April 10, 2025 (GLOBE NEWSWIRE) -- J.P. Morgan Payments, a unit of JPMorgan Chase …
Janover Purchases Approximately $4.6 Million of Solana (SOL) as Part of New Treasury Strategy
GlobeNewswire
·
April 10, 2025
BOCA RATON, FL, April 10, 2025 (GLOBE NEWSWIRE) -- Janover Inc. (Nasdaq: JNVR) (“Janover” or the “Company”) announced today the purchase of approximately $4.6 million Solana (SOL) — the first execution under its newly adopted digital asset treasury …
Unicycive Presents New Patient-Level Data Underscoring Challenges Faced with Current Phosphate Binders and Highlighting the Potential of Oxylanthanum Carbonate to Address Barriers to Adherence for Patients with Hyperphosphatemia on Dialysis
GlobeNewswire
·
April 10, 2025
– Patient-reported outcomes from Phase 2 trial of oxylanthanum carbonate (OLC) demonstrate high patient satisfaction with OLC compared to their prior phosphate lowering therapy – – Findings from a patient survey conducted in partnership with the National …
Northstrive Biosciences Signs Partnership with Yuva Biosciences to Develop AI-Powered Therapies for Obesity and Cardiometabolic Diseases
GlobeNewswire
·
April 10, 2025
Northstrive Biosciences and Yuva Biosciences’ collaboration will leverage MitoNova™, YuvaBio’s proprietary mitochondrial science-focused artificial intelligence platform, to discover and develop novel pharmaceutical treatments for obesity, type 2 diabetes …
Ottimo Pharma Strengthens Board with Appointment of Roger Dansey, M.D. to its Board of Directors
GlobeNewswire
·
April 10, 2025
Dansey, a former senior executive at Pfizer and Seagen, Inc., brings extensive experience in immuno-oncology and drug development Board appointment reinforces Company’s commitment to advancing Jankistomig, a one-of-a-kind PD-1/VEGFR2 dual paratopic …
TransUnion’s OneTru™ Accelerates Product Innovation, Delivering Exceptional Results
GlobeNewswire
·
April 10, 2025
CHICAGO, April 10, 2025 (GLOBE NEWSWIRE) -- One year ago, TransUnion (NYSE: TRU) introduced its transformative OneTru™ solution enablement platform for managing, governing, analyzing and delivering data, identity and insights. Today, OneTru delivers on its …